CF
QTTB icon

Corebridge Financial’s Q32 Bio QTTB Stock Holding History

Corebridge Financial’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,986
Closed -$4.93K – 2909
2025
Q1 		$4.93K Sell
2,986
-44
-1% -$118 ﹤0.01% 3000
2024
Q4 		$10.4K Sell
3,030
-193
-6% -$6.09K ﹤0.01% 3005
2024
Q3 		$144K Sell
3,223
-21
-0.6% -$772 ﹤0.01% 2413
2024
Q2 		$58.3K Buy
+3,244
New +$77.6K ﹤0.01% 2851

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Corebridge Financial's QTTB Position: Q2 2025 in Review

Corebridge Financial sold out of Q32 Bio (QTTB) in Q2 2025, closing a stake of 2,986 shares — an estimated $4.93K sold.

Corebridge Financial first reported a position in QTTB in Q2 2024 and held it in 4 quarters. The position peaked at $144K in Q3 2024. 61 funds tracked by Wall St. Rank hold QTTB as of Q2 2025.

  • Corebridge Financial reported no remaining Q32 Bio position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 2,986 Q32 Bio shares in Q2 2025, an estimated $4.93K.
  • Corebridge Financial first reported a position in Q32 Bio in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Q32 Bio position peaked at $144K in Q3 2024.
  • 61 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.